Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Should hydroxyethyl starch be banned?

Two recent letters in The Lancet regarding the Pharmacovigilance Risk Assessment Committee (PRAC) recommendation to suspend the marketing of hydroxyethyl starch (HES) could hardly be more different, yet both raise highly pertinent points. Djillali Annane and colleagues1 emphasise that the PRAC decision was far from unanimous, and that the European Medicines Agency’s own selected panel of experts advised PRAC against this decision. The authors further emphasised the problems that can arise in resuscitation in cases “when crystalloids alone are not sufficient”.